Page last updated: 2024-10-23

baclofen and Pain, Intractable

baclofen has been researched along with Pain, Intractable in 16 studies

Pain, Intractable: Persistent pain that is refractory to some or all forms of treatment.

Research Excerpts

ExcerptRelevanceReference
"Forty-eight patients with neuropathic pain of peripheral origin responding poorly to SCS were enrolled in a study with intrathecal baclofen; in a few cases adenosine was also tried."2.71Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study. ( Lind, G; Linderoth, B; Meyerson, BA; Winter, J, 2004)
"Phantom pain, a form of neuropathic pain, is caused by damage to somatosensible afferent nerve fibres in the peripheral or central nervous system."2.41[Pharmacotherapy for neuropathic pain caused by injury to the afferent nerve fibers]. ( Weber, WE, 2001)
"For treatment of opioid-induced myoclonus a dose reduction or a change of the opioid should be considered as well as symptomatic treatment with benzodiazepines or baclofen."1.30[Myoclonus resulting from high-dose epidural and intravenous morphine infusion]. ( Grond, S; Radbruch, L; Zech, D, 1997)
"Clonidine was added to baclofen in the pump reservoir and both drugs were administered intrathecally in combination."1.29Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. ( Middleton, JW; Molloy, AR; Rutkowski, SB; Siddall, PJ; Walker, S, 1996)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (43.75)18.2507
2000's8 (50.00)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taira, T2
Saulino, M1
Harmer, JP1
Larson, BS1
Lind, G1
Meyerson, BA1
Winter, J1
Linderoth, B1
Taha, J1
Favre, J1
Janszen, M1
Galarza, M1
Taha, A1
Plassat, R1
Perrouin Verbe, B1
Menei, P1
Menegalli, D1
Mathé, JF1
Richard, I1
Shimoyama, N1
Akizuki, A1
Takahashi, H1
Shimoyama, M1
Nayak, S1
Roberts, S1
Cunliffe, M1
Kroin, JS1
Ali, A1
York, M1
Penn, RD1
Chodakiewitz, JW1
Tanikawa, T1
Kawamura, H1
Iseki, H1
Takakura, K1
Middleton, JW1
Siddall, PJ1
Walker, S1
Molloy, AR1
Rutkowski, SB1
Tan, AK1
Tan, CB1
Radbruch, L1
Zech, D1
Grond, S1
Weber, WE1
Lazorthes, Y1
Sallerin-Caute, B1
Verdie, JC1
Bastide, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Intrathecal (IT) Baclofen Drug Distribution Pilot Study[NCT02903823]Phase 427 participants (Actual)Interventional2016-04-22Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Subjects Experiencing Maximal MAS Change From Baseline - Spasticity of Cerebral Origin

"The Modified Ashworth Scale (MAS) is a 6-point scale (Standard MAS scale values: 0, 1, 1.5, 2, 3, or 4) used to evaluate spasticity based on grading muscle tone by moving joints. The MAS scores in this cohort are measured in biceps, triceps and forearm flexor muscles in upper extremities; and quadriceps, hamstrings and gastrocnemius muscles in lower extremities. The score ranges from 0 (no increase in muscle tone) to 4 (affected part(s) rigid in flexion or extension). Improvement in spasticity was a reduction in MAS score by 1 point across a joint tested. Maximal MAS change is the sum of MAS score reduction in all four limbs tested.~This outcome looks at subjects with spasticity of cerebral origin." (NCT02903823)
Timeframe: Baseline to 6 hours post-injection

InterventionParticipants (Count of Participants)
Cervical level 4 injection siteThoracic level 3 injection siteThoracic level 10 injection siteLumbar lever 2 injection site
Subjects With Max MAS Change8733

Subjects Experiencing Maximal MAS Change From Baseline - Spasticity of Spinal Origin

"The Modified Ashworth Scale (MAS) is a 6-point scale (Standard MAS scale values: 0, 1, 1.5, 2, 3, or 4) used to evaluate spasticity based on grading muscle tone by moving joints. The MAS scores in this cohort are measured in biceps, triceps and forearm flexor muscles in upper extremities; and quadriceps, hamstrings and gastrocnemius muscles in lower extremities. The score ranges from 0 (no increase in muscle tone) to 4 (affected part(s) rigid in flexion or extension). Improvement in spasticity was a reduction in MAS score by 1 point across a joint tested. Maximal MAS change is the sum of MAS score reduction in all four limbs tested.~This outcome looks at subjects with spasticity of spinal origin." (NCT02903823)
Timeframe: Baseline to 6 hours post-injection

InterventionParticipants (Count of Participants)
Cervical spine level 4 injection siteThoracic level 3 injection siteThoracic level 10 injection siteLumbar level 2 injection site
Subjects With MAS Change - Based on Site of Injection4253

Reviews

4 reviews available for baclofen and Pain, Intractable

ArticleYear
[Chronic intrathecal drug administration for the control of intractable pain].
    Brain and nerve = Shinkei kenkyu no shinpo, 2008, Volume: 60, Issue:5

    Topics: Amines; Analgesics, Opioid; Anesthetics, Local; Baclofen; Calcium Channel Blockers; Clonidine; Cyclo

2008
[Palliative medicine for advanced gynecological malignancy].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Bone Neoplasms; Drug Therapy,

2004
[Pharmacotherapy for neuropathic pain caused by injury to the afferent nerve fibers].
    Nederlands tijdschrift voor geneeskunde, 2001, Apr-28, Volume: 145, Issue:17

    Topics: Amantadine; Analgesics, Non-Narcotic; Anticonvulsants; Antidepressive Agents, Tricyclic; Baclofen; D

2001
Advances in drug delivery systems and applications in neurosurgery.
    Advances and technical standards in neurosurgery, 1991, Volume: 18

    Topics: Adult; Aged; Aged, 80 and over; Animals; Baclofen; Brain Diseases; Equipment Design; Female; Humans;

1991

Trials

2 trials available for baclofen and Pain, Intractable

ArticleYear
Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study.
    European journal of pain (London, England), 2004, Volume: 8, Issue:4

    Topics: Administration, Oral; Adult; Aged; Analgesics; Baclofen; Electric Stimulation Therapy; Female; GABA

2004
Spinal intrathecal baclofen suppresses central pain after a stroke.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:3

    Topics: Baclofen; Cerebrovascular Disorders; Female; Humans; Injections, Spinal; Male; Middle Aged; Pain; Pa

1994

Other Studies

10 other studies available for baclofen and Pain, Intractable

ArticleYear
Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience.
    European journal of physical and rehabilitation medicine, 2012, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Baclofen; Drug Therapy, Combination; Female; Follow-Up

2012
Pain relief from baclofen analgesia in a neuropathic pain patient who failed opioid and pharmacotherapy: case report.
    Journal of pain & palliative care pharmacotherapy, 2002, Volume: 16, Issue:3

    Topics: Analgesics, Opioid; Baclofen; Female; Humans; Injections, Spinal; Middle Aged; Muscle Relaxants, Cen

2002
Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps.
    Neurosurgery, 2004, Volume: 55, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Analgesics, Opioid; Baclofen; Bupivacaine; Clon

2004
Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients.
    Spinal cord, 2004, Volume: 42, Issue:12

    Topics: Adult; Baclofen; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Fe

2004
Management of intractable pain from a chronic dislocated hip in an adolescent.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:4

    Topics: Baclofen; Catheterization; Child; Chronic Disease; Drug Tolerance; Female; Femoral Nerve; GABA Agoni

2008
The distribution of medication along the spinal canal after chronic intrathecal administration.
    Neurosurgery, 1993, Volume: 33, Issue:2

    Topics: Analgesia, Epidural; Baclofen; Endometrial Neoplasms; Female; Humans; Hydromorphone; Infusion Pumps,

1993
Managing chronic intractable pain.
    The Western journal of medicine, 1995, Volume: 162, Issue:3

    Topics: Baclofen; Humans; Infusion Pumps, Implantable; Morphine; Pain, Intractable

1995
Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study.
    Archives of physical medicine and rehabilitation, 1996, Volume: 77, Issue:8

    Topics: Adult; Baclofen; Clonidine; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Muscle

1996
The syndrome of painful legs and moving toes--a case report.
    Singapore medical journal, 1996, Volume: 37, Issue:4

    Topics: Baclofen; Clonazepam; Female; GABA Agonists; GABA Modulators; Humans; Middle Aged; Neuromuscular Dis

1996
[Myoclonus resulting from high-dose epidural and intravenous morphine infusion].
    Medizinische Klinik (Munich, Germany : 1983), 1997, May-15, Volume: 92, Issue:5

    Topics: Adult; Analgesia, Epidural; Analgesics, Opioid; Baclofen; Female; GABA Agonists; Humans; Injections,

1997